Cytokinetics Announces Data From Phase IIa "Evidence of Effect" Clinical Trial of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis to Be Presented at the 63rd Annual Meeting of the American Academy of Neurology
Benzinga Staff